BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL Medication Singapore | Medicine SG
BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL is a medication in Singapore. The dosage in INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION form, is administered by the INTRAVENOUS or SUBCUTANEOUS route. The licence is held by TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD., approved on 2023-03-03, with the number SIN16732P. The forensic classification is Prescription Only, and ATC code is L01XG01.
Permalink: https://www.medicinesg.com/sg/meds/bortezomib-teva-powder-for-solution-for-injection-3-5mg-vial/
- Licence number: SIN16732P
- Product name: BORTEZOMIB-TEVA POWDER FOR SOLUTION FOR INJECTION 3.5MG/VIAL
- License holder: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Approval date: 2023-03-03
- Forensic classification: Prescription Only
- ATC Code: L01XG01
- Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route of Administration: INTRAVENOUS or SUBCUTANEOUS
- Manufacturer & Country of manufacturer:
- Active ingredients & Strength: